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The aetiology considered in the study was cover-
age of defects after removal of massive skin cancer. 
The localization of the wounds is exemplified in 
the Table I.
The average area grafted was 185cm2 (range 
from 48 to 303 cm2), and grafts were 0.2 to 0.3 cm 
thick.
In 30 % of cases we meshed the grafts 1:3 and we 
used sutures stitches and staples almost in all cases.
The skin graft and donor site were covered by 
non-adherent dressing and a secondary medication 
of sterile gauzes over it. Skin grafts dressing were 
removed 5 days after surgery.
The percentage of the graft adherence was clini-
cally evaluated and estimated thanks to a digital soft-
ware (Bersoft Software Measurent 8.15) (Figure 1).
At an average follow up of 78 days, in 28 out 
of 33 patients (84.8%) more than 95% of the graft 
dimension adhered. In 3 out of the 5 cases where 
graft adherence was less of 95% (Table II), the graft 
was positioned over skull bone, after tumour exci-
sion that reached the periosteal tissue. In one case 
the skin graft was applied after removal of a tumour 
of the cheek invading the superficial lobes of the 
parotid gland, where salivary secretion probably 
impaired the adhesion of the graft and the surgi-
cal sealant effectiveness. In the last case graft did 
not adhere completely due to the not oncologically 
radical excision (debulking) of the tumor and its 
coherent growth after skin graft application.
In the 28 positive cases, the common complica-
tions of skin grafting (such as necrosis, infection, 
sliding, haematomas and seromas) were not ob-
served.
TO THE EDITOR: Skin grafting is one of the most 
used technique for wound coverage.1 The main fac-
tor in graft adherence is the condition of the wound 
bed, that must be well vascularized. The same im-
portance has the prevention of the haematoma or 
seroma development in the contact between the 
skin graft and the wound bed. In order to avoid 
these conditions, classical “tie over bolster” is an ad-
visable technique to achieve an optimal adhesion. 
For the same principles, it is also recommended to 
mesh the grafts and put a compressive dressing.2
In case of extended wound and in difficult areas 
where is not easy to gain a three-dimensional recon-
struction (for example in lower limb reconstruction, 
hand surgery, post traumatic and burn surgery), the 
use of the classical methods are difficult to achieve 
and not always satisfactory.3
In these cases, wound healing could be impaired 
causing a partial adhesion of the graft.
Nowadays more and more experimental evidenc-
es 4 suggest that fibrin glue should be considered as 
component of skin-graft management.
Human fibrin glue provides manifold advantag-
es combined with skin grafting. Firstly, fibrin glue 
preparation is easy and fast. The solutions are ac-
cessible to the operating room and easily prepared 
by the circulating nurse or scrub technician.
We describe the use of Quixil®, a sealant based 
on fibrin derived from human plasma, for skin grafts 
fixation on large defects due to the removal of mas-
sive skin cancers.
We selected 33 patients with extended skin can-
cer in which reconstruction with flaps was not rec-
ommendable considering their comorbidities and 
the extension of the defect after tumour excision. 
We compared this group to other 61 patients, simi-
lar in ages and clinical condition, where split thick-
ness grafts were applied without fibrin glue.
Between February 2009 and February 2012, 33 
patients (20 males and 13 females) was treated with 
human fibrin glue combined with skin grafting. 
This includes patients with an average age of 83 
years (range from 71 to 98 years). We chose grafts 
as reconstruction method instead of flaps consider-
ing old ages of the patients, their comorbidities and 
large extension of the defects.
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Table I.—Sites of skin tumors.
Localizazion N. of cases
Upper limb  6
Lower limb  6
Head 15
Pelvis  1
Neck  2
Trunk  2
Buttocks  1
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Figure 2.—Seventy-eight year patient with skin tumor excision and reconstruction with split thickness skin graft and 
human fibrin sealant.
Figure 1.—Preparation of split thickness grafts with fibrin sealant.
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During our period of observation (from February 
2009 and February 2012) we followed 61 “over 65” 
(range from 66 to 94 years) patients who underwent 
extended tumor excision with reconstruction with split 
thickness grafts without using fibrin sealant. Patients 
with complete adhesion (>95%) of the graft were 
72%. In the other patients (17 out of 61) the technique 
failed due to infection (30%, 5 patients), haematoma 
(17%, 3 patients), sliding of the graft (47%, 8 patients) 
and seroma (6%, 1 patient) (Figure 2).
Analyzing the results obtained and comparing 
the two groups, we think that human fibrin sealant 
should be used in three dimensional defects (for 
example in anatomical fold) or when the defect is 
extended and fixation with staples or tie over dress-
ing could be inadequate.
The major problem of fibrin sealant is the addi-
tional cost for the product.
We believe that, in the complications of split 
thickness graft more common in the conditions just 
illustrated, the occurence of complication as infec-
tion, haematoma, seroma would require a long term 
medication of the recipient zone increasing the total 
cost of the single patient management.
The results observed in our patients suggest how 
human fibrin sealant could be taken in considera-
tion in split thickness grafting reconstruction tech-
nique where defect after tumour excision is extend-
ed or it has a three dimensional shape.
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Table II.—Description of the 5 unsuccessful cases.
Age Sex Diagnosis Location Grafted area cm2 Adherence (%)
83 M Squamous cell carcinoma Scalp 100 80
86 M Squamous cell carcinoma Scalp 160 70
79 M Squamous cell carcinoma Scalp  90 80
71 F Squamous cell carcinoma Cheek 130 50
73 M Squamous cell carcinoma Ankle 100 50
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